Breast Cancer Non-Sponsored
A new review explores ILC’s unique radiosensitivity and how it could reshape breast cancer radiation strategies.
Genomic profiling reveals unique mutations in breast cancer in adults 65+, supporting age-specific treatment strategies.
Breastfeeding after breast cancer is safe for young BRCA carriers, new global data show—no impact on recurrence or ...
Drs Juneja, Graff, and Lustberg explore the most pressing topics in breast cancer, such as ADCs and post-CDK4/6 sequencing.
Radiation may benefit invasive lobular carcinoma, but more data is needed to guide histology-specific treatment strategies.
ADCs, ctDNA, and endocrine therapy advances headlined ASCO 2025 breast cancer updates across HER2+, HR+, and TNBC.
Triplet therapy showed promising efficacy in advanced TNBC in the ATRACTIB trial, with a 63% response rate.
Dr. Iyengar explains how metabolic health impacts cancer risk, treatment response, and outcomes across multiple tumor types.
Dr Neil Iyengar joins Winship to lead breast oncology and survivorship, with a focus on metabolic health and cancer research.
HER2DX predicts outcomes in early HER2+ breast cancer, adding prognostic value beyond standard clinical-pathologic factors.
ChatGPT shows limited accuracy and consistency in breast cancer care, highlighting the need for expert clinical judgment.
Top research highlights from ESMO Breast Cancer 2025 showcase advances in treatment and care for patients with breast cancer.
Dr. David Waterhouse shares how clinical trials can be decentralized to better serve patients in community settings.
FDA authorizes CLAIRITY BREAST, the first AI tool to predict 5-year breast cancer risk from screening mammograms.
OncoPRO is advancing ePRO use in oncology through integration tips, EOM alignment, and improved patient outcomes.
ASCO 2025 study reveals gaps in fertility counseling and awareness among patients with cancer who are of reproductive age.
New drugs like vepdegestrant and oral SERDs may reshape HR+ breast cancer treatment with novel mechanisms and CDK4/6 combos.
Dr. David Waterhouse discusses geographic barriers to TNBC trials for Black women and the case for decentralized research.
TVEC plus chemo shows promise in early TNBC, boosting immune response and survival with favorable safety profile.
Dr. Patt discusses how AI is transforming oncology care, and how to implement it responsibly and effectively.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.